CME Group Cl A saw its RS Rating increase from 69 to 72, aiming for a score of 80 for optimal growth. The stock is on the IBD Big Cap 20 list, attempting to break out of a flat base.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
CME Group Cl A Trying To Close In On Key Technical Measure
